Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: MisterED who wrote (3559)	12/13/1997 10:17:00 AM
From: Gary Strike	Read Replies (1) \| Respond to of 23519

True...if the product works, the users will pay and margins should not suffer. For a patient who purchases a product like MUSE, this has to fall somewhere near the top of Maslow's hierarchy of needs..somewhere right below the food and shelter level and just above cigarettes. Could a generic version at lower cost come into play? It sounds like the tight process control does not warrant this, at least for a couple years.